Eversept Partners as of March 31, 2025
Portfolio Holdings for Eversept Partners
Eversept Partners holds 56 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera (NTRA) | 12.8 | $126M | 894k | 141.41 | |
| GSK Sponsored Adr (GSK) | 10.3 | $102M | 2.6M | 38.74 | |
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 7.0 | $69M | 148k | 468.92 | |
| Hca Holdings (HCA) | 5.4 | $53M | 153k | 345.55 | |
| Syndax Pharmaceuticals (SNDX) | 5.3 | $52M | 4.2M | 12.29 | |
| Vera Therapeutics Cl A (VERA) | 4.6 | $46M | 1.9M | 24.02 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 4.4 | $43M | 77k | 559.39 | |
| PerkinElmer (RVTY) | 3.2 | $32M | 299k | 105.80 | |
| Healthequity (HQY) | 3.2 | $31M | 352k | 88.37 | |
| Inspire Med Sys (INSP) | 3.0 | $30M | 186k | 159.28 | |
| Protagonist Therapeutics (PTGX) | 2.7 | $27M | 547k | 48.36 | |
| Community Health Systems (CYH) | 2.3 | $23M | 8.5M | 2.70 | |
| Zimvie (ZIMV) | 2.3 | $23M | 2.1M | 10.80 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.2 | $22M | 1.4M | 15.37 | |
| Vaxcyte (PCVX) | 2.1 | $21M | 557k | 37.76 | |
| Bruker Corporation (BRKR) | 2.1 | $21M | 499k | 41.74 | |
| Centene Corporation (CNC) | 2.1 | $21M | 340k | 60.71 | |
| Miragen Therapeutics (VRDN) | 1.9 | $19M | 1.4M | 13.48 | |
| Neurocrine Biosciences (NBIX) | 1.9 | $19M | 167k | 110.60 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $18M | 58k | 308.27 | |
| Bio-techne Corporation (TECH) | 1.7 | $16M | 280k | 58.63 | |
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $16M | 2.2M | 7.50 | |
| Glaukos (GKOS) | 1.6 | $16M | 159k | 98.42 | |
| Ionis Pharmaceuticals (IONS) | 1.6 | $16M | 517k | 30.17 | |
| Travere Therapeutics (TVTX) | 1.5 | $15M | 816k | 17.92 | |
| Globus Med Cl A (GMED) | 1.4 | $14M | 193k | 73.20 | |
| Celldex Therapeutics Com New (CLDX) | 1.3 | $13M | 697k | 18.15 | |
| Align Technology (ALGN) | 0.8 | $7.8M | 49k | 158.86 | |
| Teleflex Incorporated (TFX) | 0.8 | $7.8M | 57k | 138.19 | |
| Molina Healthcare (MOH) | 0.8 | $7.8M | 24k | 329.39 | |
| Humana (HUM) | 0.8 | $7.4M | 28k | 264.60 | |
| Anthem (ELV) | 0.7 | $6.8M | 16k | 434.96 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.6 | $5.8M | 281k | 20.47 | |
| Gossamer Bio (GOSS) | 0.4 | $4.3M | 3.9M | 1.10 | |
| Zenas Biopharma (ZBIO) | 0.4 | $3.5M | 446k | 7.90 | |
| Mannkind Corp Com New (MNKD) | 0.4 | $3.5M | 698k | 5.03 | |
| Merus N V (MRUS) | 0.3 | $3.0M | 70k | 42.09 | |
| Repligen Corporation (RGEN) | 0.2 | $2.3M | 19k | 127.24 | |
| Novavax Com New (NVAX) | 0.2 | $2.3M | 366k | 6.41 | |
| Liquidia Corporation Com New (LQDA) | 0.2 | $2.2M | 151k | 14.75 | |
| Fortrea Hldgs Common Stock (FTRE) | 0.2 | $2.2M | 293k | 7.55 | |
| 89bio (ETNB) | 0.2 | $2.2M | 304k | 7.27 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.2 | $2.1M | 943k | 2.21 | |
| Avantor (AVTR) | 0.2 | $2.0M | 123k | 16.21 | |
| Icon SHS (ICLR) | 0.2 | $1.9M | 11k | 174.99 | |
| Inflarx Nv (IFRX) | 0.2 | $1.7M | 1.7M | 1.02 | |
| Amarin Corp Spons Adr New | 0.2 | $1.5M | 3.4M | 0.45 | |
| Sutro Biopharma | 0.2 | $1.5M | 2.3M | 0.65 | |
| Iteos Therapeutics | 0.1 | $1.3M | 220k | 5.97 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $962k | 257k | 3.74 | |
| Xoma Royalty Corporation Com New (XOMA) | 0.1 | $897k | 45k | 19.93 | |
| Puma Biotechnology (PBYI) | 0.1 | $816k | 276k | 2.96 | |
| Alector (ALEC) | 0.1 | $759k | 617k | 1.23 | |
| eHealth (EHTH) | 0.1 | $596k | 89k | 6.68 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $533k | 344k | 1.55 | |
| Ac Immune Sa SHS (ACIU) | 0.0 | $188k | 101k | 1.87 |
